Myrtleciclib

N/A

Report date: 2025/02/27 11:35:26
NME

Base Information

Drug NameMyrtleciclib
Drug Alias NameVS 2370VS2-370
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein blockersCyclin-dependent kinase 9 inhibitorsCyclin-dependent kinase 6 inhibitors +[4] 
TargetsMyc proto-oncogene proteinCyclin-dependent kinase 9Cyclin-dependent kinase 6 +[4] 
Therapy Area/IndicationsNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVichem Chemie
China Registration ClassN/A

Develop Information

Active CompaniesVirostatics SrlVichem Chemie
Inactive CompaniesN/A
Active IndicationsNeoplasmsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A